Lysteda FDA Approval History
FDA Approved: Yes (First approved November 13, 2009)
Brand name: Lysteda
Generic name: tranexamic acid
Dosage form: Tablets
Previous Name: XP12B
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Menorrhagia
Lysteda (tranexamic acid) is an antifibrinolytic agent for the treatment of women with menorrhagia, heavy menstrual bleeding (HMB), and its accompanying symptoms.
Development timeline for Lysteda
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
